FRIDAY, Oct. 15, 2021 (HealthDay News) — From 2015 to 2019, the prevalence of buprenorphine misuse trended downward, in accordance to a research printed on-line Oct. 15 in JAMA Network Open.Beth Han, M.D., Ph.D., M.P.H., from the U.S. National Institutes of Health in Bethesda, Maryland, and colleagues used knowledge for 214,505 grownup respondents from the 2015 to 2019 National Survey on Drug Use and Health to study previous-12 months prescription opioid use, misuse, opioid use dysfunction (OUD), and motivations for current misuse.The researchers discovered that an estimated 2.4 million U.S. adults used buprenorphine in 2019 and an estimated 0.7 million misused buprenorphine in contrast with an estimated 4.9 and three.0 million who misused hydrocodone and oxycodone, respectively. From 2015 to 2019, the prevalence of OUD with buprenorphine misuse trended downward. Among adults with OUD, the most typical motivations for the newest buprenorphine misuse had been “as a result of I’m hooked” and “to relieve bodily ache” (27.3 and 20.5 p.c, respectively). Compared with those that misused nonbuprenorphine prescription opioids, those that misused buprenorphine had been extra possible to report utilizing prescription opioids with out having their very own prescriptions. Buprenorphine misuse was related to being aged 24 to 34 and 35 to 49 years (adjusted odds ratios, 2.9 and a couple of.3, respectively), residing in nonmetropolitan areas (adjusted odds ratio, 1.8), and polysubstance use (adjusted odds ratio, 3.9, respectively), whereas there was a unfavourable affiliation with receiving remedy for drug use solely (adjusted odds ratio, 0.4).”Three-quarters of adults taking buprenorphine don’t misuse the drug,” one coauthor stated in an announcement. “Many individuals with opioid use dysfunction need assist, and as clinicians, we should deal with their sickness.”One creator disclosed ties to the biopharmaceutical and different industries.Abstract/Full Text